These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34493172)

  • 1. Latent Epstein-Barr virus infection status and prognosis in patients with newly diagnosed Hodgkin lymphoma in Southeast China: a single-center retrospective study.
    Wang C; Zou SP; Chen DG; Wang JS; Zheng YB; Chen XR; Yang Y
    Hematology; 2021 Dec; 26(1):675-683. PubMed ID: 34493172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
    Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
    J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparity analysis and prognostic value of pretreatment whole blood Epstein-Barr virus DNA load and Epstein-Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group.
    Shen Z; Hu L; Yao M; He C; Liu Q; Wang F; Gu W; Wang Y; Dong M; Zhu T; Yin T; Li F; Jin Y; Huang S; Zhang H; Sang W;
    Int J Cancer; 2022 Jan; 150(2):327-334. PubMed ID: 34520566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Infection status and prognostic significance analysis of Epstein-Barr virus in 207 cases with newly diagnosed Hodgkin's lymphoma].
    Kang S; Qin Y; He X; Zhou S; Han X; Liu P; Dong M; Zhou L; Yang J; Yang S; Zhang C; Gui L; Shi Y
    Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2594-8. PubMed ID: 26711606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infection Status and Prognosis Analysis of Epstein-Barr Virus in Patients with Newly Diagnosed Hodgkin's Lymphoma].
    Yin JJ; Liang B; Lu Y; Zhan XR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1410-1415. PubMed ID: 27784366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
    Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
    J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M; De Matteo E; Narbaitz M; Carreño FA; Preciado MV; Chabay PA
    Int J Cancer; 2013 Apr; 132(7):1572-80. PubMed ID: 22987474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Epstein-Barr virus association with pediatric non-hodgkin lymphoma in immunocompetent and in immunocompromised patients in Argentina.
    Chabay PA; De Matteo EN; Aversa L; Maglio S; Grinstein S; Preciado MV
    Arch Pathol Lab Med; 2002 Mar; 126(3):331-5. PubMed ID: 11860309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease.
    Murray PG; Billingham LJ; Hassan HT; Flavell JR; Nelson PN; Scott K; Reynolds G; Constandinou CM; Kerr DJ; Devey EC; Crocker J; Young LS
    Blood; 1999 Jul; 94(2):442-7. PubMed ID: 10397711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
    Kanakry JA; Li H; Gellert LL; Lemas MV; Hsieh WS; Hong F; Tan KL; Gascoyne RD; Gordon LI; Fisher RI; Bartlett NL; Stiff P; Cheson BD; Advani R; Miller TP; Kahl BS; Horning SJ; Ambinder RF
    Blood; 2013 May; 121(18):3547-53. PubMed ID: 23386127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
    Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
    Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma.
    Qin JQ; Yin H; Wu JZ; Chen RZ; Xia Y; Wang L; Zhu HY; Fan L; Li JY; Liang JH; Xu W
    Leuk Res; 2021 Aug; 107():106607. PubMed ID: 33957372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
    Koh YW; Yoon DH; Suh C; Huh J
    Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the Epstein-Barr virus and Hodgkin's lymphoma in the North-Eastern part of Hungary: effects on therapy and survival.
    Keresztes K; Miltenyi Z; Bessenyei B; Beck Z; Szollosi Z; Nemes Z; Olah E; Illes A
    Acta Haematol; 2006; 116(2):101-7. PubMed ID: 16914904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
    Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
    Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
    Park JH; Yoon DH; Kim S; Park JS; Park CS; Sung H; Lee SW; Huh J; Suh C
    Ann Hematol; 2016 Apr; 95(5):801-8. PubMed ID: 26883027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.
    Chang KC; Chen PC; Chang Y; Wu YH; Chen YP; Lai CH; Medeiros LJ; Su IJ; Wang HW
    Histopathology; 2017 Feb; 70(3):442-455. PubMed ID: 27632954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
    Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
    Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric Hodgkin lymphoma in 2 South American series: a distinctive epidemiologic pattern and lack of association of Epstein-Barr virus with clinical outcome.
    Chabay PA; Barros MH; Hassan R; De Matteo E; Rey G; Carrico MK; Renault IZ; Preciado MV
    J Pediatr Hematol Oncol; 2008 Apr; 30(4):285-91. PubMed ID: 18391697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changing patterns in the Epstein-Barr virus (EBV)and Hodgkin lymphoma association in Tunisia.
    Dhiab MB; Ziadi S; Saad H; Louhichi T; Trimeche M
    Ann Hematol; 2016 Sep; 95(9):1537-43. PubMed ID: 27378019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.